NIOSH Publication No. 2005-151:

NIOSH Pocket Guide to Chemical Hazards

September 2005

2-Aminopyridine

CAS
504-29-0

NH2C5H4N

RTECS
US1575000
Synonyms & Trade Names

alpha-Aminopyridine, alpha-Pyridylamine
DOT ID & Guide
2671 / 153

Exposure
Limits

NIOSH REL: TWA 0.5 ppm (2 mg/m3)
OSHA PEL: TWA 0.5 ppm (2 mg/m3)
IDLH
5 ppm See: 504290
Conversion
1 ppm = 3.85 mg/m3
Physical Description
White powder, leaflets, or crystals with a characteristic odor.
MW: 94.1
BP: 411°F
MLT: 137°F
Sol: >100%
VP(77°F): 0.8 mmHg
IP: 8.00 eV

Sp.Gr: ?
Fl.P: 154°F
UEL: ?
LEL: ?

Combustible Solid
Incompatibilities & Reactivities

Strong oxidizers
Measurement Methods
NIOSH S158 (II-4)
See: NMAM or OSHA Methods
Personal Protection & Sanitation
(See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: Daily
Provide: Quick drench
First Aid
(See procedures)
Eye: Irrigate immediately
Skin: Water flush immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
Respirator Recommendations
NIOSH/OSHA
Up to 5 ppm:
(APF = 10) Any supplied-air respirator*
(APF = 50) Any self-contained breathing apparatus with a full facepiece
Emergency or planned entry into unknown concentrations or IDLH conditions:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
Symptoms
Irritation eyes, nose, throat; headache, dizziness; excitement; nausea; high blood pressure; respiratory distress; lassitude (weakness, exhaustion); convulsions; stupor
Target Organs
central nervous system, respiratory system
See also: INTRODUCTION   See ICSC CARD: 0214